RTA LABORATUVARLARIRTA LABORATUVARLARIRTA LABORATUVARLARI

RTA LABORATUVARLARI

No trades
See on Supercharts
Market capitalization
‪1.31 B‬TRY
‪281.12 M‬TRY
‪86.03 M‬TRY
‪75.19 M‬
Beta (1Y)
0.68

About RTA LABORATUVARLARI

CEO
Saban Orçun Kalkan
Headquarters
Gebze
Employees (FY)
69
Founded
1996
ISIN
TRERTAL00018
FIGI
BBG006KY4T38
RTA Laboratuvarlari Biyolojik Ürünler Ilaç ve Makine Sanayi Ticaret AS engages in the production, research, and development in vitro diagnostics. It products include microbiology and molecule bioligy. The company was founded by Regat Ultav, Ali Tas, and M. Tayyip Türkaslan in 1996 and is headquartered in Gebze, Turkey.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of RTALB is 13.00 TRY — it has decreased by 0.46% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BIST exchange RTA LABORATUVARLARI stocks are traded under the ticker RTALB.
RTALB stock is 10.79% volatile and has beta coefficient of 0.68. Check out the list of the most volatile stocks — is RTA LABORATUVARLARI there?
Yes, you can track RTA LABORATUVARLARI financials in yearly and quarterly reports right on TradingView.
RTALB stock has risen by 7.62% compared to the previous week, the month change is a 8.24% rise, over the last year RTA LABORATUVARLARI has showed a 55.88% increase.
RTALB net income for the last quarter is ‪47.17 M‬ TRY, while the quarter before that showed ‪106.56 M‬ TRY of net income which accounts for −55.73% change. Track more RTA LABORATUVARLARI financial stats to get the full picture.
Today RTA LABORATUVARLARI has the market capitalization of ‪1.31 B‬, it has increased by 4.05% over the last week.
No, RTALB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, RTALB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RTA LABORATUVARLARI stock right from TradingView charts — choose your broker and connect to your account.
RTALB reached its all-time high on Aug 26, 2020 with the price of 27.80 TRY, and its all-time low was 0.49 TRY and was reached on May 21, 2019.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has 69.00 employees. See our rating of the largest employees — is RTA LABORATUVARLARI on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So RTA LABORATUVARLARI technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating RTA LABORATUVARLARI stock shows the buy signal. See more of RTA LABORATUVARLARI technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. RTA LABORATUVARLARI EBITDA is ‪−31.06 M‬ TRY, and current EBITDA margin is 7.93%. See more stats in RTA LABORATUVARLARI financial statements.